ClinOncolCancerRes(2011)8:191–201

incarcinogenesis,i.e.,p16INK4a,cellcycleregulation(p15INK4a),DNArepair(BRCA1)andapoptosis(DAPK).Theabnormalhypermethylationinthesesusceptiblegeneswerealsoassociatedwithunfavorableclinicaloutcome.
DNAhypomethylationincancer
Hypomethylationistheothertypeofmethylationdefectthatwasfoundinvariousmalignancies.Althoughhypomethylationwasfirstdemonstratedtohavealinkwithcancerin1983,fewdetailsareknownaboutthebiologicalsignificanceofaberrantDNAhypomethylationcomparedtohypermethylationingenesilencing.Hypo-methylationofhighlyrepeatedDNAsequences[23–26],whichresultedinthegenomicinstabilityandgene-specifichypomethylationeventsthatleadtoaberrantgeneexpression,aremainlyresponsiblefortheglobalDNAhypomethylationfoundfrequentlyindifferenttypesofcancerssuchasbreast,lung,prostate,cervical,andbraincancer,andshowtightcorrelationwiththegradeofmalignancy[27–31].Hypomethylationintumorcellswasprimarilyduetothelossofmethylationfrominterspersedrepeatsandtandemrepetitiveregionsofthegenome,includingheterochromaticDNArepeats,dispersedretrotransposons,andendogenousretroviralelement,whichmightpromotetumorformationorprogressionbyfosteringDNArearrangement[32–38].SatelliteDNAswerepairedwitharrayrepeats,whichcomposedofvariousoligonucleotidesequencesandusuallyobservedinconstitutivelyheterochromaticchro-mosomeregions.Hypomethylationofsatellite2DNAfromchromosomes1and16,andsatellite3DNAfromchromosome9areusuallyfoundinhumantumors(.50%),includinghumanhepatocellularcarcinomas,breastadenocarcinomas,andovarianepithelialcarcino-mas[32,39,40].Hypomethylationofendogenousretrotranspo-sonsandretroviralelementwerealsoassociatedwithcarcinogenesis.DNAdemethylationactivatedthetran-scriptionofretrotransponsonsretroviral-derivedele-mentsandpromotescancer-predisposing,ortumorprogression-linkedgenomicrearrangement.Frequentactivationoftheexpressionoffull-lengthtranscriptsfromretrotransposonswasfoundincertaintypesofmurinecancer[41].Severalstudiesdemonstratedthathypomethy-lationinLine-1(Longinterspersednucleotideelements)andAlu-repetitiveelementswerehigherintumorsthaninnormaltissues,suchaslymphocyticleukemia[42],hepato-cellularcarcinomas[43],prostatecarcinomasandneuroen-docrinetumors.Proto-oncogeneswerealsofoundtobeassociatedwithhypomethylationofcancer-linkedgeneregion,inadditiontothehighlyrepeatedsequences.Hypomethylationofthegene-regulatoryregionsinvolvedintheregulationofgeneexpressioncontributedtothecarcinogenesisbyalteringtherecruitmentoftranscrip-tionalfactors.Recently,theincreasinghypomethylationofproto-oncogeneshavebeenreported.Numerousproto-oncogenesthatwereupregulatedintumors(c-fos,c-myc,Ha-ras,andKi-ras)hadshownreducedlevelsofDNAmethylationcomparedtothenormalcells[44–46].
DNAmethylationiscatalyzedbyagroupofDNAmethyltransferaseenzymes(DNMTs).TheDNMTsfamily
193
containsDNMT1,DNMT1b,DNMT1o,DNMT1p,DNMT2,DNMT3a,DNMT3bwithitsisoforms,andDNMT3L.AmongtheDNMTs,DNMT1isthemostabundantDNAmethyltransferaseinmammaliancellsandfunctionsbothasamaintenancemethyltransferaseandadenovoDNAmethyltransferase[47–49].MicecarryingthehypomorphicDNMT1mutationresultedingenome-widehypomethylation,havinganincreasedriskoflymophoma[33].GloballossofDNAmethylationmayactinconcerttorelievegenerepressioningenomicregionsthatareusuallysilentinnormalcells.Thesemaydirectlyorindirectlyleadtothereexpressionofproto-oncogenesorreactivationoftransposons,followedbyincreasedgenomicinstability,andeventualtumorformationandprogression.
Histonemodificationincancer
DNAiswrappedaroundacoreofhistonestoformnucleosomes,whichisthesmalleststructuralunitofchromatin.Lysine,arginine,andserineresiduesintheN-terminaltailsofhistonesweremarkedbyvarietiesofpost-translationalmodifications(Fig.1),includingacet-ylation,methylation,phosphorylation,sumolyation,andubiqutination[50].Themodificationofhistonetailshaddirecteffectsonvariousnuclearprocesses,includinggenetranscription,recombination,replication,DNArepair,andtheorganizationofchromosomes.Genome-widestudiesrevealedthatthecombinatorialhistonemodificationpatternsinaspecificgenomicregioncanleadtoan‘open’or‘closed’chromatinstate;thus,resultingintheactivationorrepressionofgeneexpres-sion.Forinstance,histonemarks,suchasacetylationofhistoneH3lysine9and14(H3K9acandH3K14ac),trimethylationofhistoneH3lysine4(H3K4me3),andmonomethylationofhistoneH3lysine20andhistoneH2Blysine5(H4K20meandH2BK5me),ledtotran-scriptionalactivation.Ontheotherhand,di-ortrimethylatedhistoneH3lysine9(H3K9me2andH3K9me3)andtrimethylatedhistoneH3lysine27(H3K27me3)wereassociatedwithgenerepression[51–53].Inadditiontomodulatingtheaccessibilityofchromatin,combinatorialhistonemodificationcanalsoserveasamarkertorecruitsubsequentproteininteractioneffec-tors,whicharealsoinvolvedinmeditationofspecificgeneexpressionprofiles.Thecombinatorialhistonemodifications,alsocalledepigeneticcode,determinedthemanifestationofasingleeukaryoticgenomeindifferentdevelopmentalstagesandthat,ifaberrant,willgiveinitiatecancerandotherdiseases.
SimilartoDNAmethylation,thelossandgainofbothacetylationandmethylationofspecificresiduesinhistoneswerealsoobservedincancercells,implyingthealterationofgeneralabnormalhistonemodificationpatternacrossthegenome(Fig.3).DNAhypermethyla-tioninthepromoterCpG-islandsoftumor-suppressorgenesofcancerwereassociatedwithacombinatorialhistonemodificationpattern,suchaslosinghistoneH3/H4acetylationandH3K4trimethylationandgainingH3K9methylationandH3K27trimethylation,which
From bench to bedside Ta... 11页 免费 Cancer Epigenetics Study... 37...In response to these insights, epigenetic therapy is expanding to include ...
From bench to bedside Ta... 11页 免费 Dress for Success- Men 2页 ...Epigenetics, and cancer epigenetics in particular, is a bright spot in an ...
From bench to bedside ... 11页 免费 Targeting...targeting angiogenesis: Genetics and epigenetics, ...angiogenic therapy for cancer and neovascular AMD,...
Targeting the ubiquiti... 7页 免费 From bench to bedside ... 11页 ...10. Cancer Gene Therapy Liver cancer-targeting gene-viro-therapy X Liu et...
Recent studies of cancer epigenetics have revealed ... Insights from bench to bedside and vice versa....optimize HER2-targeting therapy in patients with ...
Drug associated SNP Epigenetics Changes Non-coding ...responses, gene control, targeting issues, cause ...Bench to bedside ? Bedside to bench Questions ?...
may be the advantage of the CIK cell therapy. ...B.Targeting gammadelta T lymphocytes for cancer ...from bench to bedside[J].J Biomed Biotechnol,...
Drug associated SNP Epigenetics Changes Non-coding ...responses, gene control, targeting issues, cause ...Bench to bedside ? Bedside to bench Questions ?...
Recent studies of cancer epigenetics have revealed ... Insights from bench to bedside and vice versa....optimize HER2-targeting therapy in patients with ...
热门文档